Summary of Tesaro, Inc. (NASDAQ:TSRO) Ratings as of May 17, 2018

May 17, 2018 - By Alma Kearns

Tesaro, Inc. (NASDAQ:TSRO) Corporate Logo
Big Money Sentiment decreased to 1.01 in Q4 2017. It has change of 0.20, from 2017Q3’s 1.21. The ratio turned negative due to Tesaro, Inc. positioning: 46 sold and 64 reduced. 39 funds bought stakes and 72 increased stakes. Investors holded 58.28 million in 2017Q3 but now own 57.95 million shares or 0.57% less.
Sectoral Asset Management has invested 0.38% in Tesaro, Inc. (NASDAQ:TSRO). Pnc Ser Grp Inc holds 34 shs or 0% of its capital. Pub Employees Retirement Association Of Colorado reported 0% of its capital in Tesaro, Inc. (NASDAQ:TSRO). Balyasny Asset Llc has 0.13% invested in Tesaro, Inc. (NASDAQ:TSRO). The Michigan-based Bluestein R H & has invested 0.01% in Tesaro, Inc. (NASDAQ:TSRO). Arrowmark Colorado Hldgs Limited Liability accumulated 17,627 shs or 0.01% of the stock. Employees Retirement Systems Of Ohio has 16,097 shs for 0.01% of their capital. Sabby Management Lc accumulated 9,700 shs. Assetmark Incorporated owns 9 shs for 0% of their capital. Vanguard Gru has invested 0.01% of its capital in Tesaro, Inc. (NASDAQ:TSRO). Ellington Mngmt Grp Limited Liability holds 0.06% or 4,700 shs in its capital. Sumitomo Mitsui Tru Hldgs reported 109,142 shs. Fjarde Ap invested in 0.02% or 13,254 shs. Alps holds 0.03% in Tesaro, Inc. (NASDAQ:TSRO) or 60,262 shs. Parallax Volatility Advisers L P, a California-based fund reported 8,943 shs.

Tesaro, Inc. had 7 sales and 9 insider buys since March 1, 2018. This’s net activity of $61.19 million. Hedley Mary Lynne sold $211,485 worth of Tesaro, Inc. (NASDAQ:TSRO) or 3,855 shs on Thursday, March 1. Oliveira Orlando sold $18,488 worth of Tesaro, Inc. (NASDAQ:TSRO) or 337 shs on Thursday, March 1. The insider NEW ENTERPRISE ASSOCIATES 13 LP bought 116,445 shs worth $6.68 million. Viswanathan Ravi bought $8.35M worth of Tesaro, Inc. (NASDAQ:TSRO) or 145,532 shs on Friday, March 2. MOULDER LEON O JR had bought 5,000 shs worth $284,640 on Friday, March 2. Shares for $8.35M were bought by MOTT DAVID M.

Tesaro, Inc. (NASDAQ:TSRO) Ratings Coverage

A total of 15 analysts rate Tesaro (NASDAQ:TSRO) as follows: 12 “Buy”, 3 “Hold” and 0 “Sell”. Тherefore 80% are bullish. (NASDAQ:TSRO) has 18 ratings reports on May 17, 2018 according to StockzIntelligence. On Friday, May 4 the stock of Tesaro, Inc. (NASDAQ:TSRO) has “Outperform” rating given by Credit Suisse. On Tuesday, March 27 the stock has “Buy” rating by Wedbush. On Wednesday, February 28 Wells Fargo maintained Tesaro, Inc. (NASDAQ:TSRO) with “Buy” rating. On Wednesday, February 28 Leerink Swann maintained the shares of TSRO in report with “Buy” rating. The company rating was maintained by Barclays Capital on Wednesday, February 28. The company rating was maintained by Credit Suisse on Wednesday, February 28. On Thursday, February 22 the firm earned “Outperform” rating by Evercore. On Wednesday, February 28 the firm earned “Hold” rating by Cowen & Co. On Thursday, March 1 Morgan Stanley maintained Tesaro, Inc. (NASDAQ:TSRO) with “Overweight” rating. The stock rating was maintained by Bank of America with “Buy” on Friday, May 4. Listed here are Tesaro, Inc. (NASDAQ:TSRO) PTs and latest ratings.

07/05/2018 Broker: Lake Street Rating: Buy New Target: $80.0000 Maintain
04/05/2018 Broker: Bank of America Old Rating: Buy New Rating: Buy Old Target: $94 New Target: $88 Maintain
04/05/2018 Broker: Credit Suisse Old Rating: Outperform New Rating: Outperform Old Target: $141 New Target: $128 Maintain
04/05/2018 Broker: Citigroup Old Rating: Buy New Rating: Buy Old Target: $102 New Target: $100 Maintain
04/05/2018 Broker: H.C. Wainwright Rating: Buy New Target: $104.0000 Maintain
02/05/2018 Broker: Argus Research Old Rating: Buy New Rating: Buy Old Target: $154 New Target: $110 Maintain
16/04/2018 Broker: Piper Jaffray Rating: Hold Maintain
27/03/2018 Broker: Wedbush Rating: Buy New Target: $76.0000 Maintain
28/02/2018 Broker: Cowen & Co Rating: Hold New Target: $66.0 Maintain
01/03/2018 Broker: Morgan Stanley Old Rating: Overweight New Rating: Overweight Old Target: $156 New Target: $146 Maintain

TSRO is reaching $50.58 during the last trading session, after increased 3.47%.Tesaro, Inc. has volume of 673,653 shares. Since May 17, 2017 TSRO has declined 63.82% and is downtrending. TSRO underperformed the S&P500 by 75.37%.

Tesaro, Inc., an oncology-focused biopharmaceutical company, identifies, acquires, develops, and commercializes cancer therapeutics and oncology supportive care products in the United States.The firm is valued at $2.77 billion. It markets Rolapitant, a neurokinin-1, or NK-1, receptor antagonist for the prevention of chemotherapy induced nausea and vomiting under the VARUBI brand name.Last it reported negative earnings. The firm is also developing Niraparib, an orally active and potent poly polymerase inhibitor, which is in various clinical trials to treat ovarian or breast cancers.

A couple more Tesaro, Inc. (NASDAQ:TSRO) news were posted by: Globenewswire.com which released on May 03, 2018 “TESARO Announces First-Quarter 2018 Operating Results”, also Streetinsider.com on May 16, 2018 posted “TESARO (TSRO) Announces Presentations of Abstracts at ASCO”, the next Globenewswire.com is “TESARO Announces Participation in Two Investor Conferences” on May 01, 2018. Nasdaq.com has article titled “TESARO Announces Presentations of Abstracts at the 2018 American Society of Clinical Oncology (ASCO) Annual …”.

Tesaro, Inc. (NASDAQ:TSRO) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.